The estimated Net Worth of Nathan B Pliam is at least $23.8 millió dollars as of 8 June 2015. Nathan Pliam owns over 491,835 units of Nevro Corp stock worth over $171,458 and over the last 10 years Nathan sold NVRO stock worth over $23,578,570.
Nathan has made over 1 trades of the Nevro Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently Nathan sold 491,835 units of NVRO stock worth $23,578,570 on 8 June 2015.
The largest trade Nathan's ever made was selling 491,835 units of Nevro Corp stock on 8 June 2015 worth over $23,578,570. On average, Nathan trades about 122,959 units every 0 days since 2014. As of 8 June 2015 Nathan still owns at least 36,403 units of Nevro Corp stock.
You can see the complete history of Nathan Pliam stock trades at the bottom of the page.
Nathan's mailing address filed with the SEC is C/O NEVRO CORP., 4040 CAMPBELL AVENUE, MENLO PARK, CA, 94025.
Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo és & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.
headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.
Nevro Corp executives and other stock owners filed with the SEC include: